Frailty profile precluding full-dose R-CHOP: ECOG ≥3, OR (age ≥80 with ≥1 grade-2 comorbi...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-DLBCL-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-DLBCL-NOS |
| Sources | SRC-ESMO-DLBCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Frailty profile precluding full-dose R-CHOP: ECOG ≥3, OR (age ≥80 with ≥1 grade-2 comorbidity), OR composite frailty (age ≥75 + hypoalbuminemia <3.0 + ≥2 concomitant comorbidities). |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
| Shifts algorithm | ALGO-DLBCL-1L |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "ecog",
"threshold": 3
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 80
},
{
"comparator": ">=",
"finding": "comorbidity_grade2_count",
"threshold": 1
}
]
},
{
"all_of": [
{
"comparator": ">=",
"finding": "age",
"threshold": 75
},
{
"comparator": "<",
"finding": "albumin_g_dl",
"threshold": 3.0
},
{
"comparator": ">=",
"finding": "comorbidity_count",
"threshold": 2
}
]
}
],
"type": "composite_score"
}
Notes
Tucci/Italian Lymphoma Foundation frailty score validated as predictor of R-CHOP tolerance. Frail patients: R-mini-CHOP (50% doses) per GELA LNH03-7B; R-GemOx if anthracycline contraindicated; R-bendamustine in palliative intent. This RF de-escalates from Pola-R-CHP intensification toward R-CHOP / R-mini-CHOP when frailty co-occurs with high-IPI (severity tie-break: hold > intensify > de-escalate, but here directions conflict so engine logs both and surfaces conflict to MDT).
Used By
Algorithms
ALGO-DLBCL-1L- ALGO-DLBCL-1LALGO-DLBCL-2L- ALGO-DLBCL-2L